Abstract
While allogeneic hematopoietic stem cell transplantations have a curative potential, infections and graft-versus-host disease remain significant problems. The intestinal microbiota can influence responses to cancer chemotherapy and the role of the microbiota in affecting allogeneic hematopoietic stem cell transplantation outcomes is increasingly appreciated. The following paper discusses the most recent developments in this area.
Original language | English (US) |
---|---|
Pages (from-to) | 155-161 |
Number of pages | 7 |
Journal | Best Practice and Research: Clinical Haematology |
Volume | 28 |
Issue number | 2-3 |
DOIs | |
State | Published - Jun 1 2015 |
Externally published | Yes |
Keywords
- Allo-HSCT
- Bacteremia
- Diversity
- Intestinal microbiota
- Metronidazole
- Microbial dominance
- Mortality
- Survival
ASJC Scopus subject areas
- Oncology
- Clinical Biochemistry